The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,755.00
Bid: 3,715.00
Ask: 3,765.00
Change: 20.00 (0.54%)
Spread: 50.00 (1.346%)
Open: 3,755.00
High: 3,755.00
Low: 3,755.00
Prev. Close: 3,735.00
RHIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

16 Dec 2020 07:00

RNS Number : 7752I
RHI Magnesita N.V.
16 December 2020
 

RHI Magnesita N.V.

 

("RHI Magnesita" the "Company" or the "Group")

 

Share buyback programme of up to €50 million

 

Further to its third quarter trading statement, on 22 October 2020 (the "Q3 Update"), RHI Magnesita confirms that the trading trends outlined then have continued, further strengthening the Group's confidence in its outlook. The Group continues to see gradual improvement in demand in its end markets and its order book and remains on track to deliver FY 2020 adjusted EBITA1 in line with current market expectations2. The Group has demand visibility extending into the beginning of 2021 across its order book, including now for the Industrial Projects business. 

 

RHI Magnesita's balance sheet remains strong, with liquidity of €1.2 billion and significant EBITDA covenant headroom. Due to this strong financial position, the Company's capital allocation strategy has been to prioritise investment to improve its competitive position and shareholder returns, which has included the reinstatement of the 2020 interim dividend. Given the continued resilient trading and cash generation of the Group, the Board is today taking further steps to enhance shareholder returns, through a share buyback programme of up to €50 million. On completion of this programme, the Board will review the merits of further share purchases.

 

The Board is confident that both the interim dividend which will be paid on 21 December 2020, and this share buyback, will have a limited impact on Group leverage. Furthermore, it will not compromise the Group's ability to execute its internal investment plans or its flexibility to pursue value enhancing acquisition opportunities which meet its investment criteria.

 

Details of the buyback programme

 

RHI Magnesita has, today, entered into a non-discretionary arrangement with Barclays Bank Ireland PLC ("Barclays") to purchase its ordinary shares, represented by depositary interests ("Shares"), on behalf of the Company (the "Arrangement").

 

The Arrangement allows Barclays to purchase up to 4,947,770 Shares of one euro nominal value each, during the programme, up to the value of €50 million in aggregate (the "Programme").

 

The Programme will commence on 16 December 2020 and end no later than 16 December 2021. These Share purchases under the Programme will be made on the Company's behalf and independently of, and uninfluenced by, the Company. The purpose of the share buyback is to reduce the Company's share capital in order to return value to our shareholders. The Company intends to hold the purchased shares in treasury. The Company may elect to suspend the Programme and subsequently restart it, provided that when electing to suspend or restart the Programme, the Company is not in a closed period and is not in possession of inside information in relation to its securities.

 

Any purchases of Shares pursuant to the Arrangement will be subject to the terms of the Arrangement with Barclays and, in any case, will be effected in a manner consistent with the general authority vested in the Company to repurchase Shares (as granted by shareholders at the Company's most recent annual general meeting held on 18 June 2020), the EU Market Abuse Regulation (596/2014), and Chapter 12 of the Financial Conduct Authority's Listing Rules.

 

References in this announcement, at any time after the end of the transition period relating to the United Kingdom's withdrawal from the EU, shall, in relation to anything done or to be done under or subject to UK laws, be deemed to refer to the equivalent UK provision of retained EU law.

 

1. Adjusted EBITA excludes other income and expenses

 

2. Current market expectation based on Company compiled consensus as at 22 October 2020 of 248 million

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (596/2014/EU).

 

Further information

 

Investors

Annabel Hill, Interim Head of Investor Relations +44 7792 034254

annabel.hill@rhimagnesita.com

 

Media

Matt Denham, Teneo +44 7825 735596

 

About RHI Magnesita

 

RHI Magnesita is the leading global supplier of high-grade refractory products, systems and solutions which are critical for high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves customers around the world, with around 13,000 employees in 35 main production sites and more than 70 sales offices. RHI Magnesita intends to leverage its leadership in terms of revenue, scale, product portfolio and diversified geographic presence to target strategically those countries and regions benefitting from more dynamic economic growth prospects.

 

Its shares have a premium listing on the London Stock Exchange (symbol: RHIM) and are a constituent of the FTSE 250 index, with a secondary listing on the Vienna Stock Exchange (Wiener Börse). For more information please visit: www.rhimagnesita.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFFDESIESSESE
Date   Source Headline
9th May 202412:11 pmRNSExercise of LTIP Options by PDMR
8th May 202410:03 amRNSDirector/PDMR Shareholding
3rd May 20244:12 pmRNSExercise of LTIP Options by PDMR
3rd May 20242:00 pmRNSDirector/PDMR Shareholding
2nd May 20243:56 pmRNSResult of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Update
1st May 20249:27 amRNSTotal Voting Rights
2nd Apr 20241:16 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSAcquisition of Resco Group
21st Mar 20249:03 amRNSNotice of AGM
8th Mar 20249:29 amRNSDirector/PDMR Shareholding
28th Feb 202411:50 amRNS2023 Full Year Results
1st Feb 20247:46 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
1st Dec 20239:02 amRNSTotal Voting Rights
1st Dec 20238:39 amRNSNotification of major shareholding
31st Oct 20237:00 amRNSQ3 2023 Trading Update
16th Oct 20237:00 amRNSNotification of major shareholding
3rd Oct 20237:00 amRNSAcquisition of P-D Refractories
26th Sep 202311:00 amRNSDirector Nomination
1st Sep 20237:00 amRNSTotal Voting Rights
28th Jul 202310:55 amRNSNotification of major shareholding
27th Jul 20233:47 pmRNSNotification of major shareholding
26th Jul 20237:00 amRNSRHI Magnesita half-year results
19th Jul 20233:36 pmRNSNotice of Results
10th Jul 20235:31 pmRNSResponse to partial offer extension
3rd Jul 202311:48 amRNSTotal Voting Rights
27th Jun 20238:53 amRNSResponse to partial offer
19th Jun 20233:20 pmRNSNotification of major shareholding
16th Jun 20237:00 amRNSTotal Voting Rights
16th Jun 20237:00 amRNSReplacement: Exercise of LTIP Options by PDMRs
15th Jun 20237:00 amRNSTrading Update
31st May 20231:40 pmRNSExercise of LTIP Options by PDMRs
30th May 202311:04 amRNSResponse to intended partial cash offer
24th May 20234:10 pmRNSResult of AGM 2023
5th May 20237:00 amRNSQ1 2023 Trading Update
21st Apr 20234:11 pmRNSAcquisition of Seven Refractories
13th Apr 20237:00 amRNSDebt financing update
12th Apr 20237:00 amRNSRHI Magnesita - Notice of AGM 2023
5th Apr 20235:00 pmRNSIndian subsidiary equity issuance
29th Mar 20234:47 pmRNSIndian subsidiary equity issuance
29th Mar 20237:00 amRNSAcquisition of Dalmia GSB Refractories GmbH
6th Mar 20235:39 pmRNS2023 Long Term Incentive Plan Awards
27th Feb 20237:00 amRNS2022 Full Year Results
20th Feb 20237:00 amRNSNotice of Results
13th Jan 20237:00 amRNSAcquisition of Jinan New Emei
11th Jan 20233:44 pmRNSNotification of major shareholding
1st Dec 20227:00 amRNSTotal Voting Rights
29th Nov 202212:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.